Why you should feel optimistic about the future of healthcare
September 14, 2021 | Medtech, Pharma, healthcare
It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.
Optimists have had a difficult time over the past year. However, there are many reasons to be hopeful about the future of healthcare.
The next decade will see a major transformation in health systems and healthcare, driven in part by growing digital health capabilities and medical innovations. Here are some innovations and technologies that have me excited for the future.
A cure for type 1 diabetes
The word ‘cure’ is a bit of a rarity in healthcare, with treatments predominantly designed to manage conditions or their symptoms; a cure is the holy grail.
For Doug Melton, a Harvard biologist whose children have type 1 diabetes, just managing their condition was not enough. He began work 10 years ago using stem cells to try and replicate human beta cells, which produce insulin. His company was bought out and recently launched a clinical trial of VX-880, a stem cell-derived beta cell therapy, in people with type 1 diabetes.
A CURE for type 1 diabetes is simply incredible, potentially saving people from a lifetime of careful eating, insulin injections and blood glucose tests.
Precision medicine
Precision medicine takes into account a person’s individual genetics, environment and lifestyle to match them to a treatment that will give them the best possible outcomes. Precision medicines already exist; imatinib works to treat leukaemia only when the cancer cells have a particular genetic makeup, Sotorasib targets a specific mutation in people with lung cancer to halt tumour growth, and there are many more examples.
In the future we’re going to see more and more precision medicines, as we move away from a one-size-fits-all approach, and step towards a world where clinicians can accurately predict which treatments will work best for different people. I can’t wait to live in a time when we will have a specific treatment for different forms of a condition, and every patient has the best chance of managing or even curing their disease.
Nanomedicine
You could be forgiven for reading that heading and thinking I’d read a few too many science fiction novels recently, but stay with me. Nanomedicine is the medical application of nanotechnology, which operates at the atomic or molecular scale. This technology has the potential for a diverse range of uses in healthcare, from imaging and diagnosis to drug targeting and delivery.
It’s not something that’s ridiculously out of reach either. There are companies that have developed and begun testing this technology. CytImmune Sciences recently completed a Phase I trial using gold nanoparticles to target drug delivery to tumours; BlueWillow Biologics has developed nanotech that fights viruses and bacteria. The fact that nanomedicine is no longer a far-fetched dream is hugely exciting and it will be fascinating to watch our capabilities in this area grow.
Feeling more positive yet?
Hopefully these examples have reminded you of what an incredible age we live in for medical innovation as we make things that weren’t dreamed of 20 years ago into our reality. Of course, there are countless more technologies and therapies on the horizon that probably deserve to be listed here too.
This content was provided by Say Communications
Company Details
Latest Content from Say Communications
How human differences can affect communication success by Samantha Lynne
DISC Consultant Samantha Lynne examines how human differences affect communication success.
Could hackers threaten your health?
Increasing cyber threats mean medical device providers must now take security matters more seriously, writes our Say technology blogger.
Can we ‘outsmart’ smartphone addiction by using it to develop effective health apps?
Are you guilty of repeatedly checking your phone 24/7? Our new blog explores what makes them so addictive and how understanding this may help us develop more effective health apps.
Why I think rare disease companies are more patient-centric
Guest blogger Kamlesh Sheth believes companies that specialise in rare disease tend to be more patient-centric.
Embracing the demands of the empowered ‘consumer-savvy’ patient by Ann Generlich
Our access to information, which is now constantly at our fingertips and the explosion of new technologies has shifted the buying power to increasingly ‘consumer-savvy’ patients. These are patients who choose...
A Spotlight on Healthcare Communications Advocacy by Alastair Kent
Earlier this year I received an email from Stefi Rucci asking me if I would mind if she nominated me for the Healthcare Advocate of the Year at this year’s...
Am I all grown up yet? My first year in a real, adult, full-time job.
One year at Say Communications has whizzed by. I’m in my early twenties and a recent graduate who has spent the last year working in healthcare communications. Now that my...
Lost for words? Try picturing this… by Mark Spain and Sharon Ombler-Spain
The Two Visual Thinkers' blog about the benefits of recording information visually to engage and educate a variety of audiences.
Take a walk on the wild side!
The Say Comms team are raising money for The Haemophilia Society with a walk-a-thon sponsor them here http://bit.ly/1MtvDO8
Diabetes: Let’s cut the Gordian knot by Debashis Bhattacharya and Kamlesh Sheth
Digital health specialists Aegleio suggest that a culture change is needed to cope with the rise of diabetes in the UK.